(MDB) MongoDB - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US60937P1066
Stock: Database Platform, Cloud Service, Enterprise Software, Developer Tools
Total Rating 38
Risk 61
Buy Signal 0.01
| Risk 5d forecast | |
|---|---|
| Volatility | 81.0% |
| Relative Tail Risk | -22.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.75 |
| Alpha | -24.62 |
| Character TTM | |
|---|---|
| Beta | 1.822 |
| Beta Downside | 2.400 |
| Drawdowns 3y | |
|---|---|
| Max DD | 70.88% |
| CAGR/Max DD | 0.17 |
EPS (Earnings per Share)
Revenue
Description: MDB MongoDB March 05, 2026
MongoDB, Inc. (MDB) offers a general-purpose database platform globally. Its core products include MongoDB Atlas, a multi-cloud database-as-a-service (DBaaS) solution, and MongoDB Enterprise Advanced, a commercial database server for various deployment environments. The company also provides a free version, Community Server, for developers. MongoDB operates within the Internet Services & Infrastructure sector, a growth area driven by increasing data generation and cloud adoption. The companys business model relies on a freemium approach, offering a free product to attract users and then converting them to paid enterprise solutions and cloud services.
For deeper analysis, consider exploring ValueRays comprehensive data on MDBs financials and market performance.
Headlines to watch out for
- MongoDB Atlas subscription growth drives revenue
- Enterprise Advanced adoption expands market share
- Cloud infrastructure costs impact profitability
- Competition from established database vendors intensifies
- Global IT spending trends influence demand
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: -71.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 10.01 > 1.0 |
| NWC/Revenue: 99.25% < 20% (prev 117.7%; Δ -18.45% < -1%) |
| CFO/TA 0.14 > 3% & CFO 513.5m > Net Income -71.2m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 4.65 > 1.5 & < 3 |
| Outstanding Shares: last quarter (86.5m) vs 12m ago 2.20% < -2% |
| Gross Margin: 71.75% > 18% (prev 0.73%; Δ 7102 % > 0.5%) |
| Asset Turnover: 68.54% > 50% (prev 58.49%; Δ 10.05% > 0%) |
| Interest Coverage Ratio: -10.47 > 6 (EBITDA TTM -18.3m / Interest Expense TTM 5.08m) |
Altman Z'' 0.04
| A: 0.65 (Total Current Assets 3.11b - Total Current Liabilities 669.5m) / Total Assets 3.76b |
| B: -0.51 (Retained Earnings -1.91b / Total Assets 3.76b) |
| C: -0.01 (EBIT TTM -53.2m / Avg Total Assets 3.59b) |
| D: -2.35 (Book Value of Equity -1.90b / Total Liabilities 806.5m) |
| Altman-Z'' Score: 0.04 = B |
Beneish M -2.84
| DSRI: 1.03 (Receivables 499.0m/393.1m, Revenue 2.46b/2.01b) |
| GMI: 1.02 (GM 71.75% / 73.19%) |
| AQI: 1.23 (AQ_t 0.15 / AQ_t-1 0.12) |
| SGI: 1.23 (Revenue 2.46b / 2.01b) |
| TATA: -0.16 (NI -71.2m - CFO 513.5m) / TA 3.76b) |
| Beneish M-Score: -2.84 (Cap -4..+1) = A |
What is the price of MDB shares?
As of March 10, 2026, the stock is trading at USD 270.47 with a total of 2,900,304 shares traded.
Over the past week, the price has changed by -16.78%, over one month by -24.40%, over three months by -35.40% and over the past year by +49.99%.
Over the past week, the price has changed by -16.78%, over one month by -24.40%, over three months by -35.40% and over the past year by +49.99%.
Is MDB a buy, sell or hold?
MongoDB has received a consensus analysts rating of 4.18.
Therefore, it is recommended to buy MDB.
- StrongBuy: 19
- Buy: 9
- Hold: 12
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MDB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 362.6 | 34% |
| Analysts Target Price | 362.6 | 34% |
MDB Fundamental Data Overview March 08, 2026
P/E Forward = 45.8716
P/S = 8.935
P/B = 7.4371
P/EG = 1.6716
Revenue TTM = 2.46b USD
EBIT TTM = -53.2m USD
EBITDA TTM = -18.3m USD
Long Term Debt = 23.6m USD (estimated: total debt 32.9m - short term 9.26m)
Short Term Debt = 9.26m USD (from shortTermDebt, last quarter)
Debt = 32.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.05b USD (from netDebt column, last quarter)
Enterprise Value = 19.66b USD (22.01b + Debt 32.9m - CCE 2.39b)
Interest Coverage Ratio = -10.47 (Ebit TTM -53.2m / Interest Expense TTM 5.08m)
EV/FCF = 38.66x (Enterprise Value 19.66b / FCF TTM 508.5m)
FCF Yield = 2.59% (FCF TTM 508.5m / Enterprise Value 19.66b)
FCF Margin = 20.64% (FCF TTM 508.5m / Revenue TTM 2.46b)
Net Margin = -2.89% (Net Income TTM -71.2m / Revenue TTM 2.46b)
Gross Margin = 71.75% ((Revenue TTM 2.46b - Cost of Revenue TTM 696.1m) / Revenue TTM)
Gross Margin QoQ = 73.04% (prev 71.48%)
Tobins Q-Ratio = 5.23 (Enterprise Value 19.66b / Total Assets 3.76b)
Interest Expense / Debt = 7.73% (Interest Expense 2.54m / Debt 32.9m)
Taxrate = 19.96% (3.87m / 19.4m)
NOPAT = -42.5m (EBIT -53.2m * (1 - 19.96%)) [loss with tax shield]
Current Ratio = 4.65 (Total Current Assets 3.11b / Total Current Liabilities 669.5m)
Debt / Equity = 0.01 (Debt 32.9m / totalStockholderEquity, last quarter 2.95b)
Debt / EBITDA = 57.46 (negative EBITDA) (Net Debt -1.05b / EBITDA -18.3m)
Debt / FCF = -2.07 (Net Debt -1.05b / FCF TTM 508.5m)
Total Stockholder Equity = 2.95b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.98% (Net Income -71.2m / Total Assets 3.76b)
RoE = -2.41% (Net Income TTM -71.2m / Total Stockholder Equity 2.95b)
RoCE = -1.78% (EBIT -53.2m / Capital Employed (Equity 2.95b + L.T.Debt 23.6m))
RoIC = -1.44% (negative operating profit) (NOPAT -42.5m / Invested Capital 2.95b)
WACC = 12.62% (E(22.01b)/V(22.05b) * Re(12.63%) + D(32.9m)/V(22.05b) * Rd(7.73%) * (1-Tc(0.20)))
Discount Rate = 12.63% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.26%
[DCF] Terminal Value 67.72% ; FCFF base≈353.4m ; Y1≈435.9m ; Y5≈742.4m
[DCF] Fair Price = 91.60 (EV 6.41b - Net Debt -1.05b = Equity 7.46b / Shares 81.4m; r=12.62% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 57.55 | EPS CAGR: -2.77% | SUE: 1.35 | # QB: 14
Revenue Correlation: 98.88 | Revenue CAGR: 26.78% | SUE: 2.61 | # QB: 17
EPS next Quarter (2026-04-30): EPS=1.18 | Chg7d=-0.027 | Chg30d=-0.029 | Revisions Net=+0 | Analysts=34
EPS current Year (2027-01-31): EPS=5.84 | Chg7d=+0.198 | Chg30d=+0.198 | Revisions Net=+2 | Growth EPS=+17.5% | Growth Revenue=+17.5%
EPS next Year (2028-01-31): EPS=7.01 | Chg7d=+0.222 | Chg30d=+0.224 | Revisions Net=+3 | Growth EPS=+20.1% | Growth Revenue=+17.2%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
P/S = 8.935
P/B = 7.4371
P/EG = 1.6716
Revenue TTM = 2.46b USD
EBIT TTM = -53.2m USD
EBITDA TTM = -18.3m USD
Long Term Debt = 23.6m USD (estimated: total debt 32.9m - short term 9.26m)
Short Term Debt = 9.26m USD (from shortTermDebt, last quarter)
Debt = 32.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.05b USD (from netDebt column, last quarter)
Enterprise Value = 19.66b USD (22.01b + Debt 32.9m - CCE 2.39b)
Interest Coverage Ratio = -10.47 (Ebit TTM -53.2m / Interest Expense TTM 5.08m)
EV/FCF = 38.66x (Enterprise Value 19.66b / FCF TTM 508.5m)
FCF Yield = 2.59% (FCF TTM 508.5m / Enterprise Value 19.66b)
FCF Margin = 20.64% (FCF TTM 508.5m / Revenue TTM 2.46b)
Net Margin = -2.89% (Net Income TTM -71.2m / Revenue TTM 2.46b)
Gross Margin = 71.75% ((Revenue TTM 2.46b - Cost of Revenue TTM 696.1m) / Revenue TTM)
Gross Margin QoQ = 73.04% (prev 71.48%)
Tobins Q-Ratio = 5.23 (Enterprise Value 19.66b / Total Assets 3.76b)
Interest Expense / Debt = 7.73% (Interest Expense 2.54m / Debt 32.9m)
Taxrate = 19.96% (3.87m / 19.4m)
NOPAT = -42.5m (EBIT -53.2m * (1 - 19.96%)) [loss with tax shield]
Current Ratio = 4.65 (Total Current Assets 3.11b / Total Current Liabilities 669.5m)
Debt / Equity = 0.01 (Debt 32.9m / totalStockholderEquity, last quarter 2.95b)
Debt / EBITDA = 57.46 (negative EBITDA) (Net Debt -1.05b / EBITDA -18.3m)
Debt / FCF = -2.07 (Net Debt -1.05b / FCF TTM 508.5m)
Total Stockholder Equity = 2.95b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.98% (Net Income -71.2m / Total Assets 3.76b)
RoE = -2.41% (Net Income TTM -71.2m / Total Stockholder Equity 2.95b)
RoCE = -1.78% (EBIT -53.2m / Capital Employed (Equity 2.95b + L.T.Debt 23.6m))
RoIC = -1.44% (negative operating profit) (NOPAT -42.5m / Invested Capital 2.95b)
WACC = 12.62% (E(22.01b)/V(22.05b) * Re(12.63%) + D(32.9m)/V(22.05b) * Rd(7.73%) * (1-Tc(0.20)))
Discount Rate = 12.63% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.26%
[DCF] Terminal Value 67.72% ; FCFF base≈353.4m ; Y1≈435.9m ; Y5≈742.4m
[DCF] Fair Price = 91.60 (EV 6.41b - Net Debt -1.05b = Equity 7.46b / Shares 81.4m; r=12.62% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 57.55 | EPS CAGR: -2.77% | SUE: 1.35 | # QB: 14
Revenue Correlation: 98.88 | Revenue CAGR: 26.78% | SUE: 2.61 | # QB: 17
EPS next Quarter (2026-04-30): EPS=1.18 | Chg7d=-0.027 | Chg30d=-0.029 | Revisions Net=+0 | Analysts=34
EPS current Year (2027-01-31): EPS=5.84 | Chg7d=+0.198 | Chg30d=+0.198 | Revisions Net=+2 | Growth EPS=+17.5% | Growth Revenue=+17.5%
EPS next Year (2028-01-31): EPS=7.01 | Chg7d=+0.222 | Chg30d=+0.224 | Revisions Net=+3 | Growth EPS=+20.1% | Growth Revenue=+17.2%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)